Trump administration opens the door to lower drug prices as Medicare Advantage plans are pushed to step therapy approach
The Trump administration has taken another step towards lowering drug costs for consumers, this time aiming at the millions of members in Medicare …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
